The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...
First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...
Regeneron (REGN) announced that the FDA has approved Eylea HD Injection 8 mg for the treatment of patients with macular edema following retinal ...
Kodiak Sciences has announced follow-up outcomes from the APEX study, which showed sustained clinical effect of KSI-101 through week 20 in patients with macular oedema secondary to inflammation. In ...
Older age in adults with diabetic macular edema (DME) appears to be associated with less robust visual and anatomic gains from anti-vascular endothelial growth factor (VEGF) therapy, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback